Oxycodone with Metabolite Confirmation, Random, Urine
Use
This test is useful for the detection and quantification of oxycodone, oxymorphone, noroxycodone, and noroxymorphone in urine. It assesses exposure to oxycodone within 2 to 3 days prior to specimen collection and helps in understanding the presence of these substances, which suggests recent ingestion of oxycodone or related opiates.
Special Instructions
For situations where chain of custody is required, use a Chain-of-Custody Kit. Additional panels and specific drug requests are available by contacting the laboratory. STAT requests are not accepted. If urine creatinine is required or specimen adulteration is suspected, order the Adulterants Survey test.
Limitations
This test does not detect other drugs in the opioid class such as fentanyl, meperidine, methadone, and opiate antagonists like naloxone. Submitting less than 1 mL will compromise testing. Gross hemolysis and icterus are acceptable.
New York Approved
Methodology
Mass Spectrometry (LC-MS/MS)
Biomarkers
LOINC Codes
- 94304-3
- 16249-5
- 17395-5
- 69050-3
- 61425-5
- 90894-7
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
3 mL
Minimum Volume
2.5 mL
Container
Plastic urine container
Collection Instructions
Collect a random urine specimen. No preservative.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 28 days |
| Frozen | 28 days |